Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases( )

Hannah C. Moore; Kate M. Miller; Jonathan R. Carapetis; Chris A. Van Beneden

doi:10.1093/ofid/ofac210

Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases( )

Hannah C. Moore, Kate M. Miller, Jonathan R. Carapetis, Chris A. Van Beneden

Research output: Contribution to journal › Article › peer-review

2 Citations (Web of Science)

Abstract

Group A Streptococcus (Strep A) is responsible for a significant global health and economic burden. The recent prioritization of Strep A vaccine development by the World Health Organization has prompted global research activities and collaborations. To progress this prioritization, establishment of robust surveillance for Strep A to generate updated regional disease burden estimates and to establish platforms for future impact evaluation is essential. Through the activities of the Strep A Vaccine Global Consortium (SAVAC), we have refined and harmonized surveillance protocols for 7 Strep A disease endpoints with a view that these will form part of surveillance standards for ongoing research and public health activities.

Original language	English
Pages (from-to)	S1-S4
Number of pages	4
Journal	Open Forum Infectious Diseases
Volume	9
Issue number	SUPP 1
DOIs	https://doi.org/10.1093/ofid/ofac210
Publication status	Published - 15 Sep 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ofid/ofac210Licence: CC BY

Cite this

@article{2a5f22bab5024a8995de1e5564aea7b2,

title = "Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases( )",

abstract = "Group A Streptococcus (Strep A) is responsible for a significant global health and economic burden. The recent prioritization of Strep A vaccine development by the World Health Organization has prompted global research activities and collaborations. To progress this prioritization, establishment of robust surveillance for Strep A to generate updated regional disease burden estimates and to establish platforms for future impact evaluation is essential. Through the activities of the Strep A Vaccine Global Consortium (SAVAC), we have refined and harmonized surveillance protocols for 7 Strep A disease endpoints with a view that these will form part of surveillance standards for ongoing research and public health activities.",

keywords = "epidemiology, group A Streptococcus, Streptococcus pyogenes, surveillance",

author = "Moore, {Hannah C.} and Miller, {Kate M.} and Carapetis, {Jonathan R.} and {Van Beneden}, {Chris A.}",

year = "2022",

month = sep,

day = "15",

doi = "10.1093/ofid/ofac210",

language = "English",

volume = "9",

pages = "S1--S4",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "SUPP 1",

}

TY - JOUR

T1 - Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases( )

AU - Moore, Hannah C.

AU - Miller, Kate M.

AU - Carapetis, Jonathan R.

AU - Van Beneden, Chris A.

PY - 2022/9/15

Y1 - 2022/9/15

N2 - Group A Streptococcus (Strep A) is responsible for a significant global health and economic burden. The recent prioritization of Strep A vaccine development by the World Health Organization has prompted global research activities and collaborations. To progress this prioritization, establishment of robust surveillance for Strep A to generate updated regional disease burden estimates and to establish platforms for future impact evaluation is essential. Through the activities of the Strep A Vaccine Global Consortium (SAVAC), we have refined and harmonized surveillance protocols for 7 Strep A disease endpoints with a view that these will form part of surveillance standards for ongoing research and public health activities.

AB - Group A Streptococcus (Strep A) is responsible for a significant global health and economic burden. The recent prioritization of Strep A vaccine development by the World Health Organization has prompted global research activities and collaborations. To progress this prioritization, establishment of robust surveillance for Strep A to generate updated regional disease burden estimates and to establish platforms for future impact evaluation is essential. Through the activities of the Strep A Vaccine Global Consortium (SAVAC), we have refined and harmonized surveillance protocols for 7 Strep A disease endpoints with a view that these will form part of surveillance standards for ongoing research and public health activities.

KW - epidemiology

KW - group A Streptococcus

KW - Streptococcus pyogenes

KW - surveillance

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000854957100001

U2 - 10.1093/ofid/ofac210

DO - 10.1093/ofid/ofac210

M3 - Article

C2 - 36128412

VL - 9

SP - S1-S4

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

SN - 2328-8957

IS - SUPP 1

ER -

Harmonizing Surveillance Methodologies for Group A Streptococcal Diseases( )

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this